<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0280">
 <label>56</label>
 <element-citation publication-type="journal" id="sbref0280">
  <person-group person-group-type="author">
   <name>
    <surname>Bracci</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Canini</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Puzelli</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Sestili</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Venditti</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Spada</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Donatelli</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Belardelli</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Proietti</surname>
    <given-names>E.</given-names>
   </name>
  </person-group>
  <article-title>Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level</article-title>
  <source>Vaccine.</source>
  <volume>23</volume>
  <year>2005</year>
  <fpage>2994</fpage>
  <lpage>3004</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2004.12.006</pub-id>
  <pub-id pub-id-type="pmid">15811645</pub-id>
 </element-citation>
</ref>
